Mitsubishi Chemical H1 Core Operating Profit Jumps 61% to ¥202.8 Billion; Full-Year Forecast Raised to ¥340 Billion

Mitsubishi Chemical raised core operating profit 60.9% to ¥202,848 million in the six months to September, on revenue up 13.2% to ¥2,037,094 million, with every reporting segment improving. Net profit attributable to owners fell 18.1% to ¥90,173 million because the prior-year half included profit from discontinued operations, and the group raised its full-year core operating profit forecast to ¥340,000 million.

Mitsubishi Chemical H1 FY3/2027 earnings summary

Every segment improves

Mitsubishi Chemical Group Corporation (TSE: 4188) reported consolidated results under IFRS for the first half of FY3/2027, April 1 to September 30, 2026, on November 5, 2026, under a revised segment structure. Specialty Materials lifted core operating profit 77.2% to ¥70,359 million on higher prices, stronger demand for engineering plastics used in semiconductor equipment and higher sales of carbon-fibre composite parts, much of them for robotaxis. Industrial Gases rose 15.7% to ¥107,675 million on pricing, cost cuts and acquisitions in Australia and New Zealand. MMA & Derivatives rose to ¥8,986 million on firmer MMA monomer prices despite lower volumes linked to the Middle East situation, and Basic Materials swung to ¥14,130 million from a loss of ¥8,550 million as inventory valuation improved.

Operating profit more than doubled to ¥199,677 million and profit before tax rose 165.4% to ¥182,398 million. Profit from continuing operations rose to ¥137,025 million from ¥47,635 million, but the prior-year half had also included ¥94,891 million of profit from discontinued operations, mainly the former Mitsubishi Tanabe Pharma, now Tanabe Pharma, so net profit attributable to owners fell to ¥90,173 million. Total assets eased 1.3% to ¥5,802,105 million as debt was repaid and the yen strengthened.

Full-year forecast raised

The group now expects FY3/2027 revenue of ¥4,060,000 million (+9.6%), core operating profit of ¥340,000 million (+51.1%), operating profit of ¥328,000 million and net profit attributable to owners of ¥145,000 million, up from ¥3,800,000 million, ¥305,000 million, ¥300,000 million and ¥127,000 million in its May forecast. The first half delivered 59.7% of the new core operating profit target. The dividend forecast is unchanged at ¥32 a year (¥16 interim, ¥16 year-end).

Mitsubishi Chemical Group Corporation — H1 FY3/2027 (April 1 – September 30, 2026), IFRS, consolidated. Balance-sheet rows compare September 30, 2026 with March 31, 2026; guidance and dividend rows are full-year FY3/2027 against FY3/2026. "—" indicates a figure not disclosed.
MetricH1 FY3/2027H1 FY3/2026Change
Revenue (¥ million)2,037,0941,799,124+13.2%
Core operating profit (¥ million)202,848126,110+60.9%
Operating profit (¥ million)199,67786,489+130.9%
Pre-tax profit (¥ million)182,39868,735+165.4%
Net profit attrib. to owners of parent (¥ million)90,173110,132-18.1%
Comprehensive income (¥ million)117,199194,584-39.8%
EPS (¥)66.3779.66-16.7%
Specialty Materials — core operating profit (¥ million)70,35939,698+77.2%
MMA & Derivatives — core operating profit (¥ million)8,9863,689+143.6%
Basic Materials — core operating profit (¥ million)14,130-8,550loss to profit
Industrial Gases — core operating profit (¥ million)107,67593,037+15.7%
Total assets (¥ million)5,802,1055,876,609-1.3%
Equity attrib. to owners of parent (¥ million)1,819,7371,761,675+3.3%
Equity ratio31.4%30.0%+1.4 pt
FY3/2027 guidance — revenue (¥ million)4,060,000—+9.6%
FY3/2027 guidance — core operating profit (¥ million)340,000—+51.1%
FY3/2027 guidance — operating profit (¥ million)328,000—+990.5%
FY3/2027 guidance — net profit (¥ million)145,000—n.m.
Annual dividend per share (¥)32.0032.00unchanged

JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.